NCT06733883 Music Therapy for Adolescents with Emotional Difficulties
| NCT ID | NCT06733883 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oslo University Hospital |
| Condition | Depressive Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2023-10-09 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2023-10-09 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to examine the effects of a music therapy program in adolescents aged 13-18 years old with emotional difficulties, primarily depression and possibly concurrent diagnoses of anxiety. The main questions are: * What recruitment methods, barriers, and facilitators influence study participation among adolescents with emotional difficulties receiving music therapy in the present study? * Does music therapy contribute to a significant reduction in depression and anxiety symptoms, inclusive concomitant symptoms? * How do adolescents with emotional disorders perceive participation in music therapy, and how do they articulate its potential impacts on their health and well-being? Participants will be invited to participate in a music therapy program, in addition to standard treatment given (TAU). They meet individually in the clinic with a professional music therapist once a week over a period of ten weeks. They will also do musical home exercises between the sessions. Psychiatric interviews and clinical assessments will be conducted before treatment. Assessments and questionnaires will be performed right after the therapy program and three months after ended therapy. There will also be conducted qualitative interviews with a subgroup of the participants.
Eligibility Criteria
Inclusion criteria: * adolescents 13 to 18 years * emotional difficulties Exclusion criteria: * autism spectrum disorder * mental retardation * severe depressive episode combined with high suicidal risk
Contact & Investigator
Anne M Myhre, MD Phd
PRINCIPAL INVESTIGATOR
Oslo UH
Frequently Asked Questions
Who can join the NCT06733883 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 18 Years, studying Depressive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06733883 currently recruiting?
Yes, NCT06733883 is actively recruiting participants. Contact the research team at uxmyan@ous-hf.no for enrollment information.
Where is the NCT06733883 trial being conducted?
This trial is being conducted at Oslo, Norway.
Who is sponsoring the NCT06733883 clinical trial?
NCT06733883 is sponsored by Oslo University Hospital. The principal investigator is Anne M Myhre, MD Phd at Oslo UH. The trial plans to enroll 20 participants.